Market data
Biotechnology Pharmaceuticals
Explore verified biotechnology pharmaceuticals statistics and market research reports with sourced data and trend analysis.
Latest update:
Frida Haugland
Pharmacy Industry Statistics
84% of healthcare organizations saw at least one data breach in 2024—see what this signals for pharmacy cybersecurity risk.
Life Science Industry Statistics
55 gene therapy products were approved by the FDA in 2023—see the key market and adoption stats driving life sciences next moves.
Biomedical Industry Statistics
In 2023, the FDA approved 53 novel drugs—here’s what this signals for biomedical innovation and patient access.
Specialty Pharmacy Statistics
U.S. specialty medication use hit 7.2% of adults in 2021—explore spending, growth, and patient-cost realities behind the numbers.
Pharmaceutical Industry Statistics
70% of clinical trials fail to deliver results—explore the risk, timelines, and approval outcomes behind today’s drug development.
Pharmaceutical Statistics
In 2023, the FDA approved 42 novel drugs via accelerated approval—discover the stats that show how fast new medicines reach patients.
Medtech Industry Statistics
6.9% CAGR: the global medical devices market is projected to grow from $621.0B (2023) to $1,095.7B (2030)—what it means for medtech growth and risk.
Biopharma Industry Statistics
Just 8.0% of drugs entering clinical trials reach approval—discover what this means for biopharma pipeline productivity, safety, and growth.
AI Drug Discovery Statistics
41% of pharma executives say AI is already embedded in their drug discovery process in 2024—find what that means for funding, deals, and development.
Marketing In The Biotech Industry Statistics
Biotech marketing fuels smarter decisions: $6.7B was spent on marketing analytics and attribution software in 2024—see what it unlocks for targeting.
Sustainability In The Pharma Industry Statistics
Healthcare can drive 2–5% of global emissions—and as much as 25% in some regions. See the pharma sustainability stats behind the numbers.
Sustainability In The Biotechnology Industry Statistics
Cell culture media reached a $7.1B market size in 2023—one indicator of how fast biomanufacturing inputs are scaling toward sustainability goals.
Life Sciences Tools Industry Statistics
Whole-genome sequencing can average $3,000 per sample—see the life sciences tools stats shaping scaling, speed, and performance.
Biopharmaceutical Industry Statistics
4,500+ FDA CBER inspections in 2023 underscore how closely biopharma manufacturing is overseen—explore the stats behind supply and compliance.
Biotechnology Healthcare Industry Statistics
FDA had 7,000+ active INDs in 2024—see how investigational drug pipelines translate into faster biopharma development.
Biotech Healthcare Industry Statistics
Gene therapies made up 7.3% of all FDA drug approvals in 2023—see how biotech evidence, CRO outsourcing, and decentralized trials are speeding access.
Japan Pharmacy Industry Statistics
A prescription is dispensed in a median 15.2 minutes in Japan—see what that means for access, quality, and day-to-day pharmacy performance.
Global Pharmaceutical Industry Statistics
Global biologics are valued at $313B in 2023—fueling the fastest pharma segment. Explore the data behind growth, drug classes, and therapies.
Drug Industry Statistics
3,310 drug shortage notifications were issued by the FDA in FY 2023—what triggers shortages, what drives them, and what it means for patient access.
Vietnam Pharmaceutical Industry Statistics
Vietnam imported $8.2B in pharmaceutical products in 2023—showing heavy reliance on imported medicines and active ingredients. Explore the data behind today’s industry.